AstraZeneca (AZN) Enters Brodalumab Licensing Agreement with Valeant (VRX)
Go back to AstraZeneca (AZN) Enters Brodalumab Licensing Agreement with Valeant (VRX)| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $2.64 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 46 | |||||
| VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) | Delayed: 23.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.40 | 52 Week High | $119.86 | |||
| Open | $23.40 | 52 Week Low | $13.77 | |||
| Day High | $23.40 | P/E | N/A | |||
| Day Low | $23.40 | EPS | $0.00 | |||
| Volume | 378,733 | |||||

